Lichen Planus and Lichen Sclerosus Etiology and Triggers

Autoimmune Factors

Immune dysregulation is considered one of the most accepted theories for both conditions, with evidence of organ-specific antibodies found in patients with lichen sclerosus 1
Patients with lichen sclerosus show an increased incidence of other autoimmune conditions, including diabetes, vitiligo, and alopecia 1
In a study of 350 women with lichen sclerosus, 22% had autoimmune disease, 42% had auto-antibodies, and 60% had at least one autoimmune-related phenomenon 1

Several infectious agents have been linked with lichen sclerosus, including acid-fast bacilli and spirochetes 1
Borrelia burgdorferi has been linked to lichen sclerosus, as it causes acrodermatitis chronica atrophicans and shares clinical and histological features with lichen sclerosus 1
Human papillomavirus (HPV) has been linked to pediatric penile lichen sclerosus 1
Hepatitis C virus has been reported in case studies, potentially triggering an autoimmune reaction 1

The highest incidence of female lichen sclerosus occurs in postmenopausal women, suggesting hormonal factors may play a role 2, 3
Most cases of lichen sclerosus in females occur in the fifth to sixth decade of life, with only 7-15% occurring in prepubertal girls 2
In contrast, lichen sclerosus occurs earlier in males (30-49 years old) and has been reported in children as young as 7 years 4

Some authors believe that scarring or trauma may trigger the onset of lichen sclerosus by inducing skin lesions typical to the disorder 5, 3
Sexual abuse has been suggested as a potential trigger for lichen sclerosus in some cases, as the resulting trauma may induce characteristic skin lesions 5
Lichen sclerosus has been found to occur within herpes zoster scars, though not due to persistence of the virus itself 1

Lichen sclerosus is most common in white individuals and has been reported as uncommon in other ethnicities 2
There is a marked gender disparity, with lichen sclerosus being 6-10 times more common in women than men 2

Lichen sclerosus presents as white, atrophic patches with a predilection for the anogenital area in both men and women, with pathognomonic histopathological features including hyperkeratosis of the epithelium, hydropic degeneration of basal cells, sclerosis of subepithelial collagen, dermal lymphocytic infiltration, atrophic epidermis with loss of rete pegs, and homogenization of collagen in the upper third of dermis 6
Lichen sclerosus is more common in white subjects and has been reported as uncommon in other ethnicities, with a higher prevalence in women than men, ranging from 6:1 to 10:1 7
In men, lichen sclerosus may present as phimosis, meatal stenosis, or urethral stricture, while in women, it can cause labial fusion, clitoral phimosis, and introital narrowing 6

The first-line treatment for lichen sclerosus is topical clobetasol propionate 0.05% cream applied twice daily for 2-3 months, with surgical intervention indicated for disease progression despite medical management and anatomical complications 6
Regular follow-up is essential for lichen sclerosus due to the 4-5% risk of squamous cell carcinoma, with alternative treatments for non-responsive cases including systemic retinoids, stanazolol, hydroxychloroquine, potassium para-aminobenzoate, and calcitriol 6

Lichen sclerosus has a well-established association with squamous cell carcinoma, with a risk of 4-5%, emphasizing the importance of regular monitoring for non-healing lesions 6

Biopsy is essential for diagnosing both lichen sclerosus and lichen planus to confirm the diagnosis and rule out squamous cell carcinoma, with different histopathological features distinguishing these conditions 6
Biopsy is mandatory before initiating treatment to confirm diagnosis and rule out malignancy 6